Stock Scorecard
Stock Summary for Cross Country Healthcares Inc (CCRN) - $7.95 as of 12/22/2025 7:28:13 AM EST
Total Score
10 out of 30
Safety Score
23 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for CCRN
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for CCRN
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for CCRN
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for CCRN
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for CCRN (23 out of 100)
| Stock Price Rating (Max of 10) | 4 |
| Historical Stock Price Rating (Max of 10) | 7 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 5 |
| Book Value to Price (Max of 10) | 8 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 8 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for CCRN
Financial Details for CCRN
Company Overview |
|
|---|---|
| Ticker | CCRN |
| Company Name | Cross Country Healthcares Inc |
| Country | N/A |
| Description | Cross Country Healthcare, Inc. is a leading provider of innovative talent management solutions and consulting services focused on the U.S. healthcare sector. Headquartered in Boca Raton, Florida, the company offers a comprehensive suite of workforce staffing and technology solutions aimed at improving operational efficiency and patient care outcomes. With a diverse array of services that include recruitment, staffing, and workforce optimization, Cross Country Healthcare stands as a vital partner for healthcare organizations seeking to address the complexities of talent acquisition and management in an ever-evolving market. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL CARE FACILITIES |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 7.95 |
| Price 4 Years Ago | 27.76 |
| Last Day Price Updated | 12/22/2025 7:28:13 AM EST |
| Last Day Volume | 992,983 |
| Average Daily Volume | 1,188,547 |
| 52-Week High | 18.30 |
| 52-Week Low | 7.43 |
| Last Price to 52 Week Low | 7.00% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 22.32 |
| Sector PE | 53.39 |
| 5-Year Average PE | 42.94 |
| Free Cash Flow Ratio | 2.62 |
| Industry Free Cash Flow Ratio | 94.50 |
| Sector Free Cash Flow Ratio | 33.77 |
| Current Ratio Most Recent Quarter | 3.45 |
| Total Cash Per Share | 3.03 |
| Book Value Per Share Most Recent Quarter | 12.55 |
| Price to Book Ratio | 0.64 |
| Industry Price to Book Ratio | 2.58 |
| Sector Price to Book Ratio | 49.15 |
| Price to Sales Ratio Twelve Trailing Months | 0.23 |
| Industry Price to Sales Ratio Twelve Trailing Months | 0.98 |
| Sector Price to Sales Ratio Twelve Trailing Months | 14.97 |
| Analyst Buy Ratings | 0 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 32,760,000 |
| Market Capitalization | 260,442,000 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 3.45% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -78.50% |
| Annual Earnings Growth | -120.04% |
| Reported EPS 12 Trailing Months | -0.49 |
| Reported EPS Past Year | 0.08 |
| Reported EPS Prior Year | 0.45 |
| Net Income Twelve Trailing Months | -15,676,000 |
| Net Income Past Year | -14,556,000 |
| Net Income Prior Year | 72,631,000 |
| Quarterly Revenue Growth YOY | -20.60% |
| 5-Year Revenue Growth | 10.33% |
| Operating Margin Twelve Trailing Months | 0.32% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 99,132,000 |
| Total Cash Past Year | 81,633,000 |
| Total Cash Prior Year | 17,094,000 |
| Net Cash Position Most Recent Quarter | 40,166,000 |
| Net Cash Position Past Year | -212,400,000 |
| Long Term Debt Past Year | 294,033,000 |
| Long Term Debt Prior Year | 294,033,000 |
| Total Debt Most Recent Quarter | 58,966,000 |
| Equity to Debt Ratio Past Year | 0.59 |
| Equity to Debt Ratio Most Recent Quarter | 0.87 |
| Total Stockholder Equity Past Year | 418,959,000 |
| Total Stockholder Equity Prior Year | 473,393,000 |
| Total Stockholder Equity Most Recent Quarter | 408,142,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 45,671,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 1.39 |
| Free Cash Flow Past Year | 111,402,000 |
| Free Cash Flow Prior Year | 234,524,000 |
Options |
|
| Put/Call Ratio | 2.18 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.96 |
| MACD Signal | -0.96 |
| 20-Day Bollinger Lower Band | 8.20 |
| 20-Day Bollinger Middle Band | 12.01 |
| 20-Day Bollinger Upper Band | 15.82 |
| Beta | 0.42 |
| RSI | 30.59 |
| 50-Day SMA | 13.98 |
| 150-Day SMA | 17.88 |
| 200-Day SMA | 19.70 |
System |
|
| Modified | 12/22/2025 7:39:15 PM EST |